Name:
Ethinamate
Type:
Sedative
AKA:
Valmid, Valamin
Ethinamate image
Synthetic substance, no natural derivative
IUPAC Logo
Ethinamate image
Ethinamate, a sedative-hypnotic, was introduced in the 1950s. It was used to treat anxiety and insomnia but was eventually discontinued due to safety concerns and the development of newer medications.
Synthetic Substances Image
Ethinamate, a sedative-hypnotic drug introduced in the 1950s, acts as a downer, inducing sleep and relaxation. Physical impacts include decreased heart rate, respiratory depression, and dilated pupils. Short-term use is effective for treating insomnia, but long-term use may result in tolerance and dependence. Overdose risks include severe respiratory depression and potential death. Safe use involves careful dosing and monitoring. Recent research focuses on its efficacy in treating sleep disorders and its safety compared to other sedatives.
N/A
Ethinamate, a sedative-hypnotic, affects GABA-A receptors, providing sedation and mood alteration. Immediate effects include relaxation and cognitive impairment, with long-term use potentially leading to dependence and cognitive decline. Research explores its use in sedation and potential psychological impacts.
N/A
Ethinamate, a sedative-hypnotic drug, has no historical or cultural lore but gained prominence in the mid-20th century for treating insomnia and anxiety. Its cultural significance is tied to discussions about the safety and efficacy of sedatives. Proponents emphasize its therapeutic benefits, while opponents caution about its potential for dependence and side effects. Its use is strictly medicinal, reflecting broader themes in the history of sedative use and the evolution of treatments for anxiety and sleep disorders.
N/A